Spruce Biosciences Bolsters Commercial Leadership with Appointment of Brian Walls as VP, Market Access, and Darren Johnson as VP, Commercial Operations Spruce Biosciences, a late-stage biopharmaceutical company focused on developing and commercializing therapies for neurological disorders with significant unmet medical…
OpRegen® 3-Year Data in Geographic Atrophy Patients Showcased at Foundation Fighting Blindness Retinal Innovation Summit 2026 Lineage Cell Therapeutics (NYSE American and TASE: LCTX), a clinical-stage biotechnology company focused on developing off-the-shelf allogeneic cell therapies for serious medical conditions, has…
Insulet Launches EVOLVE Pivotal Trial to Accelerate Development of a Fully Closed-Loop Insulin Delivery System for Type 2 Diabetes Insulet Corporation, a global pioneer in tubeless insulin pump technology through its Omnipod® platform, has taken a significant step forward in…
UCB Expands Immunology Pipeline with Planned Acquisition of Candid Therapeutics and Its Novel T-Cell Engager Platform UCB has taken a significant step forward in its strategic expansion within immunology by entering into a definitive agreement to acquire Candid Therapeutics, a…
Knoa Pharma Launches as Public Health-Focused Company Aiming to Support Patients and Combat the Opioid Crisis Knoa Pharma LLC has officially launched as a newly established independent organization with a mission centered on improving public health, ensuring responsible access to…
CorFlow Therapeutics Reports Phase 1 Completion, Initiates Phase 2 Enrollment in MOCA II Trial, Gains EU Approval for REVITALISE RCT, and Expands Clinical Leadership CorFlow Therapeutics AG has announced a series of important clinical and organizational milestones that mark significant…
Ansa Biotechnologies to Highlight Next-Generation DNA Synthesis Innovation with Industry-Exclusive On-Time Delivery Guarantee at SynBioBeta 2026 Ansa Biotechnologies, a biotechnology firm specializing in next-generation DNA synthesis solutions, has announced its participation and presentation lineup for the upcoming SynBioBeta 2026 conference,…
Vensica Medical Secures FDA IND Clearance to Launch Phase 2 Trial of ViXe, a Needle-Free Xeomin® Delivery System for Overactive Bladder Vensica Medical, an emerging innovator in the field of needle-free therapeutic delivery technologies, has announced a significant regulatory milestone…
Anova’s Global Urology Research Network Expands with Addition of 500th Urology Research Site Anova Enterprises, Inc. has announced a major expansion of its virtual urology research network, marking a significant milestone in the evolution of digitally enabled clinical trials. Powered…
Encoded Therapeutics to Present ETX101 Clinical Data in Dravet Syndrome at the 2026 ASGCT Presidential Symposium Encoded Therapeutics Inc. has announced its participation in the American Society of Gene & Cell Therapy 2026 Annual Meeting, where it will present new…
Dispatch Bio Showcases SEND-Based T Cell Armoring Approach at the ASGCT 2026 Annual Meeting Dispatch Bio has announced the presentation of new preclinical data highlighting its innovative SEND (Synthetic Efficacy eNableD) T cell armoring strategy at the upcoming American Society…
Mundipharma Reports Positive Phase III ReSPECT Topline Results for ▼REZZAYO (rezafungin) in Preventing Invasive Fungal Diseases in Allogeneic Stem Cell Transplant Patients Mundipharma has announced encouraging topline results from its pivotal Phase III ReSPECT clinical trial, highlighting the potential of…